Whole-genome sequencing in triple-negative breast cancer supports the prognostic value of the HRDetect mutational-signature-based algorithm for improving patient stratification in a real-world, population-based clinical diagnostic setting.
- Johan Staaf
- Dominik Glodzik
- Serena Nik-Zainal